Explore more publications!

Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on December 11, 2025

Lightspeed Verified by Common Sense Privacy with an Exceptional 95% Score
DanReDev Expands National Portfolio as Daniel Kaufman  Accelerates Workforce Housing, BTR, and AI-Ready Projects
LifeSafer Partners with A+ Academy Driving School to Enable Safer Driving for Teens
Unity Environmental University’s Enterprise Digital Transformation: From CAMS to Salesforce-as-SIS with Tondro
Jens Erik Gould on AI’s Limits and the Strategic Role of Nearshore Talent on Legal Talk Network’s ‘Un-Billable Hour’
Quorum Software Appoints Kathleen Creech as Executive Vice President and Chief People Officer
Cycle Pharmaceuticals to Acquire Applied Therapeutics
TTEC Recognized as a Major Contender in Everest Group’s 2025 Sales Services PEAK Matrix® Assessment
Scrum Alliance Secures Multiple Wins in Comparably's 2025 Rankings
Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry
Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia (CAH)
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Datavault AI Inc. (NASDAQ: DVLT) Announces a Distribution Date of Dec. 24, 2025, for the Dream Bowl Meme Coin Tokens to All Eligible Record Equity Holders of Datavault AI and Holders of Common Stock of Scilex Holding Company
Dyne Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
Datavault AI Inc. (NASDAQ: DVLT) Announces a Distribution Date of Dec. 24, 2025, for the Dream Bowl Meme Coin Tokens to All Eligible Record Equity Holders of Datavault AI and Holders of Common Stock of Scilex Holding Company
Oruka Therapeutics Announces New Board Member and Board Transition
Nusano Receives “Best Companies to Work For” Award from Utah Business
Kymera Therapeutics Announces Closing of Upsized $602 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Tenaya Therapeutics Announces Rapid Resolution and Lifting of Clinical Hold for MyPEAK-1™ Phase 1b/2a Clinical Trial of TN-201 Gene Therapy
Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions